REGENXBIO INC (RGNX:NASDAQ)
$9.69 -0.43 (-4.249%)
Analysed REGENXBIO INC (RGNX:NASDAQ) News Sources
FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy
23-06-2026
pharmaceutical-technology.com
Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II
23-06-2026
yahoo.com
REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
24-06-2026
yahoo.com
REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
29-06-2026
yahoo.com
REGENXBIO Announces Proposed Public Offering of Common Stock
16-07-2026
yahoo.com
RGNX Stock Slumps 15% After-Hours — What’s Driving The Selloff?
16-07-2026
stocktwits.com
REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
17-07-2026
yahoo.com
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
18-07-2026
yahoo.com
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
22-07-2026
yahoo.com
New Strong Sell Stocks for July 23rd
23-07-2026
yahoo.com
What is the current price of REGENXBIO INC (RGNX:NASDAQ)?
The current price of REGENXBIO INC (RGNX:NASDAQ) is $9.69.
REGENXBIO INC (RGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is $-0.43.
REGENXBIO INC (RGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is -4.249%.
What is the most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ)?
The most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for REGENXBIO INC (RGNX:NASDAQ)?
The most recent sentiment for REGENXBIO INC (RGNX:NASDAQ) is .
SEC-8K** Filing Available For REGENXBIO INC (RGNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.